Duchesne, G. M., Woo, H. H., Bassett, J. K., Bowe, S. J., D'Este, C., Frydenberg, M., King, M., Ledwich, L., Loblaw, A., Malone, S., Millar, J., Milne, R., Smith, R. G., Spry, N., Stockler, M., Syme, R. A., Tai, K. H., & Turner, S. (n.d.). timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. Lancet oncology, 17(6), 727–737. http://access.bl.uk/ark:/81055/vdc_100032476377.0x000033